Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mauro KL"'
Publikováno v:
Labor & Engenho, Vol 7, Iss 2 (2013)
Enfaticamente nas cidades globais e, em especial nas brasileiras, o processo de ocupação urbana de forma cada vez mais concentrada e densificada tem se refletido em impactos negativos nos recursos hídricos e ambientais. As cheias e inundações, a
Externí odkaz:
https://doaj.org/article/1b6cd738a00b4033879bdf2145ef832b
Autor:
Gonçalves SF; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: sgoncal@gmu.edu., Mauro KL; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States., Kinsey-Kerr MG; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States., Fuentes AG; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States., Thompson JC; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States., Chaplin TM; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States.
Publikováno v:
Neuropsychologia [Neuropsychologia] 2022 Nov 05; Vol. 176, pp. 108371. Date of Electronic Publication: 2022 Sep 19.
Autor:
Chaplin TM; George Mason University, Fairfax, VA, USA. tchaplin@gmu.edu., Mauro KL; George Mason University, Fairfax, VA, USA., Niehaus CE; George Mason University, Fairfax, VA, USA.
Publikováno v:
Current topics in behavioral neurosciences [Curr Top Behav Neurosci] 2022; Vol. 54, pp. 341-372.
Neural activation to loss and reward among alcohol naive adolescents who later initiate alcohol use.
Autor:
Gonçalves SF; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: sgoncal@gmu.edu., Turpyn CC; Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC, 27599, United States. Electronic address: cturpyn@email.unc.edu., Niehaus CE; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: cniehaus@gmu.edu., Mauro KL; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: kmauro2@gmu.edu., Hinagpis CL; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: chinagpi@gmu.edu., Thompson JC; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: jthompsz@gmu.edu., Chaplin TM; Department of Psychology, George Mason University, Fairfax, VA, 22030, United States. Electronic address: tchaplin@gmu.edu.
Publikováno v:
Developmental cognitive neuroscience [Dev Cogn Neurosci] 2021 Aug; Vol. 50, pp. 100978. Date of Electronic Publication: 2021 Jun 17.
Autor:
Chaplin TM; Department of Psychology, George Mason University, Fairfax, VA, USA. tchaplin@gmu.edu., Mauro KL; Department of Psychology, George Mason University, Fairfax, VA, USA., Curby TW; Department of Psychology, George Mason University, Fairfax, VA, USA., Niehaus C; Department of Psychology, George Mason University, Fairfax, VA, USA., Fischer S; Department of Psychology, George Mason University, Fairfax, VA, USA., Turpyn CC; Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, NC, USA., Martelli AM; Psychology Department, Virginia Commonwealth University, Richmond, VA, USA., Miller AB; Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, NC, USA., Leichtweis RN; Inova Kellar Center, Fairfax, VA, USA., Baer R; Oxford Mindfulness Center, University of Oxford, Oxford, England., Sinha R; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Publikováno v:
Research on child and adolescent psychopathology [Res Child Adolesc Psychopathol] 2021 Jul; Vol. 49 (7), pp. 861-875. Date of Electronic Publication: 2021 Feb 23.
Autor:
Mauro KL; From the, Youth Emotion Lab, (KLM, SFG, TMC), George Mason University, Fairfax, Virginia., Goncalves SF; From the, Youth Emotion Lab, (KLM, SFG, TMC), George Mason University, Fairfax, Virginia., Sinha R; Yale Stress Center, (RS), Yale University School of Medicine, New Haven, Connecticut., Ansell E; Biobehavioral Health, (EA), Pennsylvania State University, University Park, Pennsylvania., Chaplin TM; From the, Youth Emotion Lab, (KLM, SFG, TMC), George Mason University, Fairfax, Virginia.
Publikováno v:
Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2020 Jul; Vol. 44 (7), pp. 1420-1430. Date of Electronic Publication: 2020 May 28.
Autor:
Rosoff DB; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Charlet K; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.; Department of Psychiatry and Psychotherapy, Charite-Universitaetsmedizin Berlin, Berlin, Germany., Jung J; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Lee J; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Muench C; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Luo A; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Longley M; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Mauro KL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Lohoff FW; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2019 Jun 05; Vol. 2 (6), pp. e195844. Date of Electronic Publication: 2019 Jun 05.
Autor:
Lohoff FW; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. falk.lohoff@nih.gov., Sorcher JL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Rosen AD; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Mauro KL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Fanelli RR; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Momenan R; Section on Brain and Electrophysiology and Imaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Hodgkinson CA; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Vendruscolo LF; Neurobiology of Addiction Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Koob GF; Neurobiology of Addiction Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Schwandt M; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., George DT; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Jones IS; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Holmes A; Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Zhou Z; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Xu MJ; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Gao B; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Sun H; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Phillips MJ; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Muench C; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Kaminsky ZA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2018 Sep; Vol. 23 (9), pp. 1900-1910. Date of Electronic Publication: 2017 Aug 29.
Autor:
Mauro KL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Helton SG; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Rosoff DB; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Luo A; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Schwandt M; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Jung J; Epidemiology & Biometry Branch, Division of Epidemiology and Prevention Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Ln., Rockville, MD, USA., Lee J; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Muench C; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA., Lohoff FW; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive (10CRC), Bethesda, MD, USA.
Publikováno v:
Alcohol and alcoholism (Oxford, Oxfordshire) [Alcohol Alcohol] 2018 Jul 01; Vol. 53 (4), pp. 361-367.
Autor:
Lee JS; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Sorcher JL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Rosen AD; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Damadzic R; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Sun H; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Schwandt M; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Heilig M; Department of Clinical and Experimental Medicine, Center for Social and Affective Neuroscience, Linkoping University, Sweden., Kelly J; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mauro KL; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Luo A; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Rosoff D; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Muench C; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Jung J; Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Kaminsky ZA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Lohoff FW; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2018 Jun; Vol. 42 (6), pp. 1034-1043. Date of Electronic Publication: 2018 May 09.